Concepedia

Stephen Noell

SN

Statistics

Publications

19

Citations

3.6K

H-Index

16

Active since

2012

Affiliations

Pfizer (United States)(Current)

Utah State University

California Institute for Biomedical Research

Southern Research Institute

University of Maryland, Baltimore

Stephen Noell is an author at Pfizer (United States) specializing in pharmacology, drug discovery, and antiviral therapy.

Publications per year

2012–2025

19

Publications

19

An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.9K citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19

Robert L. Hoffman, Robert S. Kania, Mary A. Brothers et al. · Journal of Medicinal Chemistry · 2020 · 533 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +15

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 296 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

S.E. Greasley, Stephen Noell, Olga Plotnikova et al. · Journal of Biological Chemistry · 2022 · 174 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 159 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 19